1 / 10

Turnover & ebitda ( MM€ / yEAR )

Turnover & ebitda ( MM€ / yEAR ). GADEA STAFF. 35% PhD and Graduate. CYNDEA PHARMA FINISHED FORMS FACILITIES. LINE 1. LINE 2. LINE 3. Soft Gel Capsules. Hormonal Oral Tablets. Oral Tablets. Viales oftálmicos estériles. Jeringuillas precargadas estériles.

gore
Download Presentation

Turnover & ebitda ( MM€ / yEAR )

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Turnover & ebitda (MM€/yEAR)

  2. GADEA STAFF 35% PhD and Graduate

  3. CYNDEA PHARMA FINISHED FORMS FACILITIES LINE 1 LINE 2 LINE 3 • Soft Gel Capsules • Hormonal Oral Tablets • Oral Tablets

  4. Viales oftálmicos estériles Jeringuillas precargadas estériles Liofilización estéril en bulk Viales liofilizados estériles

  5. Strain improvement programs • Classical mutation & screening • Genetic engineering • Pilot fermentation: 5-12.000 L

  6. PROPUESTAS DE COOPERACIÓN • Nuevastecnologías de producción de APIs • Microorganismos productores de APIs • Desarrollosde formasterminadasestériles • Desarrollosanalíticos

  7. CONTACTO José-Luis Barredo BiotechnologyManaging Director GADEA BIOPHARMA – GADEA Grupo Farmacéutico www.gadea.com Parque Tecnológico de León 24009 León – Spain Tel.: +34 983 54 80 72 Fax: + 34 983 54 81 13 Mob.: +34 697 42 39 83 E-mail: joseluis.barredo@gadea.com Skype: jose.luis.barredo.fuente

More Related